Malaria
Recent findings in malaria provide new insights
Published in Medical Letter on the CDC and FDA, May 29th, 2005
Study 1: Mutations in pfmdr1 associated with chloroquine resistance incur a fitness cost in Plasmodium falciparum.
According to a study from Australia, "Efforts to control malaria worldwide have been hindered by the development and expansion of parasite populations resistant to many first-line antimalarial compounds. Two of the best-characterized determinants of drug resistance in the human malaria parasite Plasmodium falciparum are pfmdr1 and pfcrt, although the mechanisms by which resistance is mediated by these genes is still not clear."
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Avian Influenza Virus
Pathogenic avian influenza viruses found in live bird markets in Hanoi - Diabetes Survival and Mortality
Depression increases mortality among persons with diabetes - Escherichia Coli
Epidemiology of E. coli O157:H7 outbreaks in U.S. reported - Sexually Transmitted Disease
Applying case-crossover design reduces confounding in condom efficacy - Viral Clearance
Re-use of ion chromatography media does not decrease virus removal - Adverse Drug Reaction
Monitoring program finds serious, unreported adverse drug reactions - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
